{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:23:15Z","timestamp":1789053795830,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18ck0106435h0001"],"award-info":[{"award-number":["18ck0106435h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health and Labor Sciences Research Grants"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1038\/s41375-021-01171-y","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T02:03:31Z","timestamp":1614737011000},"page":"1480-1484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome"],"prefix":"10.1038","volume":"35","author":[{"given":"Genki","family":"Yamato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminori","family":"Terui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0061-9781","authenticated-orcid":false,"given":"Tsutomu","family":"Toki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7582-0201","authenticated-orcid":false,"given":"Asahito","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7710-2449","authenticated-orcid":false,"given":"Shotaro","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yokosuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko M.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Horibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souichi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-4766","authenticated-orcid":false,"given":"Takashi","family":"Taga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8801-0021","authenticated-orcid":false,"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"1171_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1055\/s-2005-836510","volume":"217","author":"C Langebrake","year":"2005","unstructured":"Langebrake C, Creutzig U, Reinhardt D. Immunophenotype of down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts. Klin Padiatr. 2005;217:126\u201334.","journal-title":"Klin Padiatr"},{"key":"1171_CR2","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","volume":"110","author":"SR Pine","year":"2007","unstructured":"Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood. 2007;110:2128\u201331.","journal-title":"Blood."},{"key":"1171_CR3","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1182\/blood-2011-04-350017","volume":"118","author":"AS Gamis","year":"2011","unstructured":"Gamis AS, Alonzo TA, Gerbing RB, Hilden JM, Sorrell AD, Sharma M, et al. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children\u2019s Oncology Group Study A2971. Blood. 2011;118:6752\u20139.","journal-title":"Blood."},{"key":"1171_CR4","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","volume":"111","author":"JH Klusmann","year":"2008","unstructured":"Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008;111:2991\u20138.","journal-title":"Blood."},{"key":"1171_CR5","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","volume":"107","author":"GV Massey","year":"2006","unstructured":"Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW, et al. Children\u2019s Oncology Group (COG). A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children\u2019s Oncology Group (COG) study POG-9481. Blood. 2006;107:4606\u201313.","journal-title":"Blood."},{"key":"1171_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1365-2141.2008.07231.x","volume":"142","author":"H Muramatsu","year":"2008","unstructured":"Muramatsu H, Kato K, Watanabe N, Matsumoto K, Nakamura T, Horikoshi Y, et al. Risk factors for early death in neonates with Down syndrome and transient leukaemia. Br J Haematol. 2008;142:610\u20135.","journal-title":"Br J Haematol"},{"key":"1171_CR7","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1182\/blood-2002-12-3904","volume":"101","author":"G Mundschau","year":"2003","unstructured":"Mundschau G, Gurbuxani S, Gamis AS, Greene ME, Arceci RJ, Crispino JD. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood. 2003;101:4298\u2013300.","journal-title":"Blood."},{"key":"1171_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng955","volume":"32","author":"J Wechsler","year":"2002","unstructured":"Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32:148\u201352.","journal-title":"Nat Genet"},{"key":"1171_CR9","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1182\/blood-2011-03-342774","volume":"118","author":"KA Alford","year":"2011","unstructured":"Alford KA, Reinhardt K, Garnett C, Norton A, B\u00f6hmer K, von Neuhoff C, et al. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia. Blood. 2011;118:2222\u201338.","journal-title":"Blood."},{"key":"1171_CR10","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1182\/blood-2010-05-282426","volume":"116","author":"R Kanezaki","year":"2010","unstructured":"Kanezaki R, Toki T, Terui K, Xu G, Wang R, Shimada A, et al. Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia. Blood. 2010;116:4631\u20138.","journal-title":"Blood."},{"key":"1171_CR11","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1182\/bloodadvances.2018018945","volume":"2","author":"M Flasinski","year":"2018","unstructured":"Flasinski M, Scheibke K, Zimmermann M, Creutzig U, Reinhardt K, Verwer F, et al. Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study. Blood Adv. 2018;2:1532\u201340.","journal-title":"Blood Adv"},{"key":"1171_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/bjh.15390","volume":"182","author":"O Tunstall","year":"2018","unstructured":"Tunstall O, Bhatnagar N, James B, Wright M. British Society for Haematology. Guidelines for the investigation and management of transient leukaemia of down syndrome. Br J Haematol. 2018;182:200\u201311.","journal-title":"Br J Haematol"},{"key":"1171_CR13","doi-asserted-by":"publisher","first-page":"e0224097","DOI":"10.1371\/journal.pone.0224097","volume":"14","author":"V Balagopal","year":"2019","unstructured":"Balagopal V, Hantel A, Kadri S, Steinhardt G, Zhen CJ, Kang W, et al. Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing. PLoS ONE. 2019;14:e0224097.","journal-title":"PLoS ONE"},{"key":"1171_CR14","first-page":"S35","volume":"66","author":"T Yokosuka","year":"2019","unstructured":"Yokosuka T, Sakurai Y, Miyagawa N, Keino D, Iwasaki F, Hamanoue S, et al. In vitro testing of trametinib in transient abnormal myelopoiesis [abstract]. Pediatr Blood Cancer. 2019;66:S35\u201336.","journal-title":"Pediatr Blood Cancer."},{"key":"1171_CR15","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2013-07-515148","volume":"122","author":"I Roberts","year":"2013","unstructured":"Roberts I, Alford K, Hall G, Juban G, Richmond H, Norton A, et al. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood. 2013;122:3908\u201317.","journal-title":"Blood."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-021-01171-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-021-01171-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-021-01171-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:42:03Z","timestamp":1684618923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01171-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1038\/s41375-021-01171-y","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"4 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}